Clinical applications of optical coherence tomography for the diagnosis and management of macular diseases

Ophthalmology Clinics of North America

Volumn 17, Issue 1, 2004, Pages 21-31

  Voo, Irene ^a   Mavrofrides, Elias C ^a   Puliafito, Carmen A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; DEXAMETHASONE PLUS TOBRAMYCIN; KETOROLAC; PREDNISOLONE; TRIAMCINOLONE;

ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; DIABETIC RETINOPATHY; DIAGNOSTIC PROCEDURE; EPIRETINAL MEMBRANE; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PATIENT CARE; PRIORITY JOURNAL; PSEUDOPHAKIA; RETINA DETACHMENT; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; RETINA MACULA HOLE; TREATMENT OUTCOME; VEIN OCCLUSION; VITREORETINOPATHY;

EID: 1942539772     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2003.12.002     Document Type: Review

References (13)

1. Huang D., Swanson E.A., Lin C.P., Schuman J.S., Stinson W.G., Chang W.et al. Optical coherence tomography. Science. 254(5035):1991;1178-1181.
2. Hee M.R., Izatt J.A., Swanson E.A., Huang D., Schuman J.S., Lin C.P.et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 113(3):1995;325-332.
3. Drexler W., Sattmann H., Hermann B., Ko T.H., Stur M., Unterhuber A.et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol. 121:2003;695-706.
4. Puliafito C.A., Hee M.R., Lin C.P., Reichel E., Schuman J.S., Duker J.S.et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 102(2):1995;217-229.
5. Ip M.S., Baker B.J., Duker J.S., Reichel E., Baumal C.R., Gangnon R.et al. Anatomical outcomes of surgery for idiopathic macular hole as determined by optical coherence tomography. Arch Ophthalmol. 120:2002;29-35.
6. Shahidi M., Ogura Y., Blair N.P.et al. Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch Ophthalmol. 109:1991;1115-1119.
7. Moss S.E., Klein R., Klein B.E. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 105(6):1998;998-1003.
8. Hee M.R., Puliafito C.A., Wong C., Duker J.S., Reichel E., Rutledge B.et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 113(8):1995;1019-1029.
9. Yang C.S., Cheng C.Y., Lee F.L., Hsu W.M., Liu J.H. Quantitative assessment of retinal thickness in diabetic patients with and without clinically significant macular edema using optical coherence tomography. Acta Ophthalmol Scand. 79(3):2001;266-270.
10. Hee M.R., Puliafito C.A., Duker J.S., Reichel E., Coker J.G., Wilkins J.R.et al. Topography of diabetic macular edema with optical coherence tomography. Ophthalmology. 105(2):1998;360-370.
11. Martidis A., Duker J.S., Greenberg P.B., Rogers A.H., Puliafito C.A., Reichel E.et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology. 109(5):2002;920-926.
12. Rivellese M., George A., Sulkes D., Reichel E., Puliafito C.A. Optical coherence tomography after laser photocoagulation for clinically significant macular edema. Ophthalmic Surg Lasers. 31(3):2000;192-197.
13. Lattanzio R., Brancato R., Pierro L., Bandello F., Laccher B., Fiore T.et al. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol. 12(6):2002;482-487.